Skip to content
Lower risk Medical device recall · FDA · Published September 24, 2024

Siemens Healthcare Epoc BUN Test Cards Recall: Negative Sodium Bias Risk

Siemens Healthcare recalls epoc BGEM BUN Test Cards with potential negative sodium bias that could affect blood test accuracy. No injuries reported, but affected lots expired before recall.

🇺🇸 FDA recall #Z-0286-2025Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics Inc2 Edgewater Dr · Norwood, MA 02062-4637
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling epoc BGEM BUN Test Cards that may show negative sodium bias in blood tests. This could lead to inaccurate results, but no injuries have been reported. The affected lots expired before the recall was issued. Read more at govinfonow.com/recall/53874-siemens-healthcare-epoc-bun-test-cards-recall-negative-sodium-bias.

Source Summary by GovInfoNow · govinfonow.com/recall/53874-siemens-healthcare-epoc-bun-test-cards-recall-negative-sodium-bias · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0286-2025

Cite this page

“Siemens Healthcare Epoc BUN Test Cards Recall: Negative Sodium Bias Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53874-siemens-healthcare-epoc-bun-test-cards-recall-negative-sodium-bias. Based on FDA recall #Z-0286-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0286-2025%22&limit=1).

Siemens Healthcare Diagnostics Inc. recalled epoc BGEM BUN Test Cards for the epoc Blood Analysis System on Sept. 24, 2024, due to a potential negative sodium bias in one lot, according to the FDA. The company initiated this voluntary Class II recall after confirming the issue in internal testing.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System
  • SMN: 10736515
  • UDI-DI: 00809708121860
  • Lot Numbers: 08-24092-60, 08-24093-60, 08-24094-60, 08-24095-60, 08-24096-60
  • Quantity: 1292 units
  • Distribution: US Nationwide and Canada

The hazard

The recall addresses a negative sodium bias that may exist in the test cards approximately two months prior to expiration, with an observed maximum negative bias of -10 mmol/L from internal testing. One customer complaint has been associated with this issue, but no adverse events have been reported. Quality Control fluid may or may not detect the issue depending on the bias magnitude and testing frequency.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has had 150 other recalls on record since June 7, 2017. Recent brand-specific recalls include the Atellica CH RCRP Test recall from Aug. 17, 2026, and the Atellica CH Urine Albumin Recall from July 6, 2026. Other recent recalls of similar products include the Vivoo Test Strips Recall (Nov. 22, 2025), the AVID Medical Haylard 18G Epi Tray Recall (Aug. 10, 2026), and the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026).

How to tell if you have this one

Check for lot numbers 08-24092-60 through 08-24096-60 on the test card packaging. The test cards are for the epoc Blood Analysis System and expired before the recall was issued.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Test Card Lot Number

    Look for lot numbers 08-24092-60 through 08-24096-60 on the test card packaging.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide. Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Sep 24, 202412. FDA classified it Class II: Nov 1, 202423. Published in FDA’s Enforcement Report: Nov 13, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0286-2025 (September 24, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0286-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA